EN
Be the global leader of T cell cancer immunotherapy
 
Management Team
  • Alex Lei
    Alex Lei
    Ph.D., CTO
    Broad experience in immuno-engineering and manufacturing technology development.
  • Jun Wang
    Jun Wang
    M.D.,Ph.D.,Sr. Medical Consultant
    Senior clinical and regulatory leadership experience for cell therapies and other cancer therapeutics.
    20+ years clinical academic experience and 10+ years pharmaceutical industry experience. Has held senior positions in leading pharmaceutical companies such as MSD, Novartis, and Roche.
  • Li-Feng Zhang
    Li-Feng Zhang
    Ph.D., R&D Director, PI Head
    18+ years research experience with deep expertise in cell biology and cell therapy.
  • Rui Chen
    Rui Chen
    Ph.D., R&D Director, PI Head
    Specialist in immune regulation, T-cell biology;
    Multiple publications on virology, microRNA signaling, senescence.
  • Si Li
    Si Li
    Ph.D., Associate Director, R&D US
    Cancer immunologist with specialization in cell engineering, gene therapy, and virology.
  • Dawn Sheng
    Dawn Sheng
    J.D., Head of Legal & Compliance
    Experienced in corporate legal affairs;
    Well-trained attorney in China and the United States (Sidley, Weil, King & Wood Mallesons)

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer